Göran Gannedahl
Direttore/Membro del Consiglio presso ECTIN RESEARCH AB
Profilo
Göran Gannedahl is currently the Director at Ectin Research AB since 2022.
Previously, he worked as the VP-Medical, Regulatory Affairs & Research at Pronova BioPharma ASA from 2008 to 2012.
He holds a doctorate degree from Karolinska Institutet and the University of Uppsala.
Posizioni attive di Göran Gannedahl
| Società | Posizione | Inizio |
|---|---|---|
| ECTIN RESEARCH AB | Direttore/Membro del Consiglio | 01/05/2022 |
Precedenti posizioni note di Göran Gannedahl
| Società | Posizione | Fine |
|---|---|---|
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Göran Gannedahl
| Karolinska Institutet | Doctorate Degree |
| University of Uppsala | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ECTIN RESEARCH AB | Health Technology |
| Aziende private | 1 |
|---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
- Borsa valori
- Insiders
- Göran Gannedahl